Global Oral GLP-1 Agonist Market Growth 2024-2030

May 2024 | 83 pages | ID: G9DB6420EB57EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.

The global Oral GLP-1 Agonist market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Oral GLP-1 Agonist Industry Forecast” looks at past sales and reviews total world Oral GLP-1 Agonist sales in 2023, providing a comprehensive analysis by region and market sector of projected Oral GLP-1 Agonist sales for 2024 through 2030. With Oral GLP-1 Agonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral GLP-1 Agonist industry.

This Insight Report provides a comprehensive analysis of the global Oral GLP-1 Agonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral GLP-1 Agonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral GLP-1 Agonist market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral GLP-1 Agonist and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral GLP-1 Agonist.

United States market for Oral GLP-1 Agonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Oral GLP-1 Agonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Oral GLP-1 Agonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Oral GLP-1 Agonist players cover Novo Nordisk, Eli Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral GLP-1 Agonist market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Semaglutide
• Non-peptide

Segmentation by Application:

• Diabetes
• Obesity

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Novo Nordisk
• Eli Lilly

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral GLP-1 Agonist market?

What factors are driving Oral GLP-1 Agonist market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oral GLP-1 Agonist market opportunities vary by end market size?

How does Oral GLP-1 Agonist break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral GLP-1 Agonist Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Oral GLP-1 Agonist by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Oral GLP-1 Agonist by Country/Region, 2019, 2023 & 2030
2.2 Oral GLP-1 Agonist Segment by Type
  2.2.1 Semaglutide
  2.2.2 Non-peptide
2.3 Oral GLP-1 Agonist Sales by Type
  2.3.1 Global Oral GLP-1 Agonist Sales Market Share by Type (2019-2024)
  2.3.2 Global Oral GLP-1 Agonist Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Oral GLP-1 Agonist Sale Price by Type (2019-2024)
2.4 Oral GLP-1 Agonist Segment by Application
  2.4.1 Diabetes
  2.4.2 Obesity
2.5 Oral GLP-1 Agonist Sales by Application
  2.5.1 Global Oral GLP-1 Agonist Sale Market Share by Application (2019-2024)
  2.5.2 Global Oral GLP-1 Agonist Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Oral GLP-1 Agonist Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Oral GLP-1 Agonist Breakdown Data by Company
  3.1.1 Global Oral GLP-1 Agonist Annual Sales by Company (2019-2024)
  3.1.2 Global Oral GLP-1 Agonist Sales Market Share by Company (2019-2024)
3.2 Global Oral GLP-1 Agonist Annual Revenue by Company (2019-2024)
  3.2.1 Global Oral GLP-1 Agonist Revenue by Company (2019-2024)
  3.2.2 Global Oral GLP-1 Agonist Revenue Market Share by Company (2019-2024)
3.3 Global Oral GLP-1 Agonist Sale Price by Company
3.4 Key Manufacturers Oral GLP-1 Agonist Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Oral GLP-1 Agonist Product Location Distribution
  3.4.2 Players Oral GLP-1 Agonist Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ORAL GLP-1 AGONIST BY GEOGRAPHIC REGION

4.1 World Historic Oral GLP-1 Agonist Market Size by Geographic Region (2019-2024)
  4.1.1 Global Oral GLP-1 Agonist Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Oral GLP-1 Agonist Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oral GLP-1 Agonist Market Size by Country/Region (2019-2024)
  4.2.1 Global Oral GLP-1 Agonist Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Oral GLP-1 Agonist Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oral GLP-1 Agonist Sales Growth
4.4 APAC Oral GLP-1 Agonist Sales Growth
4.5 Europe Oral GLP-1 Agonist Sales Growth
4.6 Middle East & Africa Oral GLP-1 Agonist Sales Growth

5 AMERICAS

5.1 Americas Oral GLP-1 Agonist Sales by Country
  5.1.1 Americas Oral GLP-1 Agonist Sales by Country (2019-2024)
  5.1.2 Americas Oral GLP-1 Agonist Revenue by Country (2019-2024)
5.2 Americas Oral GLP-1 Agonist Sales by Type (2019-2024)
5.3 Americas Oral GLP-1 Agonist Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral GLP-1 Agonist Sales by Region
  6.1.1 APAC Oral GLP-1 Agonist Sales by Region (2019-2024)
  6.1.2 APAC Oral GLP-1 Agonist Revenue by Region (2019-2024)
6.2 APAC Oral GLP-1 Agonist Sales by Type (2019-2024)
6.3 APAC Oral GLP-1 Agonist Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Oral GLP-1 Agonist by Country
  7.1.1 Europe Oral GLP-1 Agonist Sales by Country (2019-2024)
  7.1.2 Europe Oral GLP-1 Agonist Revenue by Country (2019-2024)
7.2 Europe Oral GLP-1 Agonist Sales by Type (2019-2024)
7.3 Europe Oral GLP-1 Agonist Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral GLP-1 Agonist by Country
  8.1.1 Middle East & Africa Oral GLP-1 Agonist Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Oral GLP-1 Agonist Revenue by Country (2019-2024)
8.2 Middle East & Africa Oral GLP-1 Agonist Sales by Type (2019-2024)
8.3 Middle East & Africa Oral GLP-1 Agonist Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral GLP-1 Agonist
10.3 Manufacturing Process Analysis of Oral GLP-1 Agonist
10.4 Industry Chain Structure of Oral GLP-1 Agonist

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Oral GLP-1 Agonist Distributors
11.3 Oral GLP-1 Agonist Customer

12 WORLD FORECAST REVIEW FOR ORAL GLP-1 AGONIST BY GEOGRAPHIC REGION

12.1 Global Oral GLP-1 Agonist Market Size Forecast by Region
  12.1.1 Global Oral GLP-1 Agonist Forecast by Region (2025-2030)
  12.1.2 Global Oral GLP-1 Agonist Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Oral GLP-1 Agonist Forecast by Type (2025-2030)
12.7 Global Oral GLP-1 Agonist Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Novo Nordisk
  13.1.1 Novo Nordisk Company Information
  13.1.2 Novo Nordisk Oral GLP-1 Agonist Product Portfolios and Specifications
  13.1.3 Novo Nordisk Oral GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Novo Nordisk Main Business Overview
  13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
  13.2.1 Eli Lilly Company Information
  13.2.2 Eli Lilly Oral GLP-1 Agonist Product Portfolios and Specifications
  13.2.3 Eli Lilly Oral GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Eli Lilly Main Business Overview
  13.2.5 Eli Lilly Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oral GLP-1 Agonist Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Oral GLP-1 Agonist Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Semaglutide
Table 4. Major Players of Non-peptide
Table 5. Global Oral GLP-1 Agonist Sales by Type (2019-2024) & (Units)
Table 6. Global Oral GLP-1 Agonist Sales Market Share by Type (2019-2024)
Table 7. Global Oral GLP-1 Agonist Revenue by Type (2019-2024) & ($ million)
Table 8. Global Oral GLP-1 Agonist Revenue Market Share by Type (2019-2024)
Table 9. Global Oral GLP-1 Agonist Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Oral GLP-1 Agonist Sale by Application (2019-2024) & (Units)
Table 11. Global Oral GLP-1 Agonist Sale Market Share by Application (2019-2024)
Table 12. Global Oral GLP-1 Agonist Revenue by Application (2019-2024) & ($ million)
Table 13. Global Oral GLP-1 Agonist Revenue Market Share by Application (2019-2024)
Table 14. Global Oral GLP-1 Agonist Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Oral GLP-1 Agonist Sales by Company (2019-2024) & (Units)
Table 16. Global Oral GLP-1 Agonist Sales Market Share by Company (2019-2024)
Table 17. Global Oral GLP-1 Agonist Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Oral GLP-1 Agonist Revenue Market Share by Company (2019-2024)
Table 19. Global Oral GLP-1 Agonist Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Oral GLP-1 Agonist Producing Area Distribution and Sales Area
Table 21. Players Oral GLP-1 Agonist Products Offered
Table 22. Oral GLP-1 Agonist Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oral GLP-1 Agonist Sales by Geographic Region (2019-2024) & (Units)
Table 26. Global Oral GLP-1 Agonist Sales Market Share Geographic Region (2019-2024)
Table 27. Global Oral GLP-1 Agonist Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Oral GLP-1 Agonist Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Oral GLP-1 Agonist Sales by Country/Region (2019-2024) & (Units)
Table 30. Global Oral GLP-1 Agonist Sales Market Share by Country/Region (2019-2024)
Table 31. Global Oral GLP-1 Agonist Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Oral GLP-1 Agonist Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Oral GLP-1 Agonist Sales by Country (2019-2024) & (Units)
Table 34. Americas Oral GLP-1 Agonist Sales Market Share by Country (2019-2024)
Table 35. Americas Oral GLP-1 Agonist Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Oral GLP-1 Agonist Sales by Type (2019-2024) & (Units)
Table 37. Americas Oral GLP-1 Agonist Sales by Application (2019-2024) & (Units)
Table 38. APAC Oral GLP-1 Agonist Sales by Region (2019-2024) & (Units)
Table 39. APAC Oral GLP-1 Agonist Sales Market Share by Region (2019-2024)
Table 40. APAC Oral GLP-1 Agonist Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Oral GLP-1 Agonist Sales by Type (2019-2024) & (Units)
Table 42. APAC Oral GLP-1 Agonist Sales by Application (2019-2024) & (Units)
Table 43. Europe Oral GLP-1 Agonist Sales by Country (2019-2024) & (Units)
Table 44. Europe Oral GLP-1 Agonist Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Oral GLP-1 Agonist Sales by Type (2019-2024) & (Units)
Table 46. Europe Oral GLP-1 Agonist Sales by Application (2019-2024) & (Units)
Table 47. Middle East & Africa Oral GLP-1 Agonist Sales by Country (2019-2024) & (Units)
Table 48. Middle East & Africa Oral GLP-1 Agonist Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Oral GLP-1 Agonist Sales by Type (2019-2024) & (Units)
Table 50. Middle East & Africa Oral GLP-1 Agonist Sales by Application (2019-2024) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Oral GLP-1 Agonist
Table 52. Key Market Challenges & Risks of Oral GLP-1 Agonist
Table 53. Key Industry Trends of Oral GLP-1 Agonist
Table 54. Oral GLP-1 Agonist Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oral GLP-1 Agonist Distributors List
Table 57. Oral GLP-1 Agonist Customer List
Table 58. Global Oral GLP-1 Agonist Sales Forecast by Region (2025-2030) & (Units)
Table 59. Global Oral GLP-1 Agonist Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Oral GLP-1 Agonist Sales Forecast by Country (2025-2030) & (Units)
Table 61. Americas Oral GLP-1 Agonist Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Oral GLP-1 Agonist Sales Forecast by Region (2025-2030) & (Units)
Table 63. APAC Oral GLP-1 Agonist Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Oral GLP-1 Agonist Sales Forecast by Country (2025-2030) & (Units)
Table 65. Europe Oral GLP-1 Agonist Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Oral GLP-1 Agonist Sales Forecast by Country (2025-2030) & (Units)
Table 67. Middle East & Africa Oral GLP-1 Agonist Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Oral GLP-1 Agonist Sales Forecast by Type (2025-2030) & (Units)
Table 69. Global Oral GLP-1 Agonist Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Oral GLP-1 Agonist Sales Forecast by Application (2025-2030) & (Units)
Table 71. Global Oral GLP-1 Agonist Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Novo Nordisk Basic Information, Oral GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk Oral GLP-1 Agonist Product Portfolios and Specifications
Table 74. Novo Nordisk Oral GLP-1 Agonist Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. Eli Lilly Basic Information, Oral GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 78. Eli Lilly Oral GLP-1 Agonist Product Portfolios and Specifications
Table 79. Eli Lilly Oral GLP-1 Agonist Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Eli Lilly Main Business
Table 81. Eli Lilly Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Oral GLP-1 Agonist
Figure 2. Oral GLP-1 Agonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral GLP-1 Agonist Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Oral GLP-1 Agonist Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Oral GLP-1 Agonist Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Oral GLP-1 Agonist Sales Market Share by Country/Region (2023)
Figure 10. Oral GLP-1 Agonist Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Semaglutide
Figure 12. Product Picture of Non-peptide
Figure 13. Global Oral GLP-1 Agonist Sales Market Share by Type in 2023
Figure 14. Global Oral GLP-1 Agonist Revenue Market Share by Type (2019-2024)
Figure 15. Oral GLP-1 Agonist Consumed in Diabetes
Figure 16. Global Oral GLP-1 Agonist Market: Diabetes (2019-2024) & (Units)
Figure 17. Oral GLP-1 Agonist Consumed in Obesity
Figure 18. Global Oral GLP-1 Agonist Market: Obesity (2019-2024) & (Units)
Figure 19. Global Oral GLP-1 Agonist Sale Market Share by Application (2023)
Figure 20. Global Oral GLP-1 Agonist Revenue Market Share by Application in 2023
Figure 21. Oral GLP-1 Agonist Sales by Company in 2023 (Units)
Figure 22. Global Oral GLP-1 Agonist Sales Market Share by Company in 2023
Figure 23. Oral GLP-1 Agonist Revenue by Company in 2023 ($ millions)
Figure 24. Global Oral GLP-1 Agonist Revenue Market Share by Company in 2023
Figure 25. Global Oral GLP-1 Agonist Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Oral GLP-1 Agonist Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Oral GLP-1 Agonist Sales 2019-2024 (Units)
Figure 28. Americas Oral GLP-1 Agonist Revenue 2019-2024 ($ millions)
Figure 29. APAC Oral GLP-1 Agonist Sales 2019-2024 (Units)
Figure 30. APAC Oral GLP-1 Agonist Revenue 2019-2024 ($ millions)
Figure 31. Europe Oral GLP-1 Agonist Sales 2019-2024 (Units)
Figure 32. Europe Oral GLP-1 Agonist Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Oral GLP-1 Agonist Sales 2019-2024 (Units)
Figure 34. Middle East & Africa Oral GLP-1 Agonist Revenue 2019-2024 ($ millions)
Figure 35. Americas Oral GLP-1 Agonist Sales Market Share by Country in 2023
Figure 36. Americas Oral GLP-1 Agonist Revenue Market Share by Country (2019-2024)
Figure 37. Americas Oral GLP-1 Agonist Sales Market Share by Type (2019-2024)
Figure 38. Americas Oral GLP-1 Agonist Sales Market Share by Application (2019-2024)
Figure 39. United States Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Oral GLP-1 Agonist Sales Market Share by Region in 2023
Figure 44. APAC Oral GLP-1 Agonist Revenue Market Share by Region (2019-2024)
Figure 45. APAC Oral GLP-1 Agonist Sales Market Share by Type (2019-2024)
Figure 46. APAC Oral GLP-1 Agonist Sales Market Share by Application (2019-2024)
Figure 47. China Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 51. India Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Oral GLP-1 Agonist Sales Market Share by Country in 2023
Figure 55. Europe Oral GLP-1 Agonist Revenue Market Share by Country (2019-2024)
Figure 56. Europe Oral GLP-1 Agonist Sales Market Share by Type (2019-2024)
Figure 57. Europe Oral GLP-1 Agonist Sales Market Share by Application (2019-2024)
Figure 58. Germany Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 59. France Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Oral GLP-1 Agonist Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Oral GLP-1 Agonist Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Oral GLP-1 Agonist Sales Market Share by Application (2019-2024)
Figure 66. Egypt Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Oral GLP-1 Agonist Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Oral GLP-1 Agonist in 2023
Figure 72. Manufacturing Process Analysis of Oral GLP-1 Agonist
Figure 73. Industry Chain Structure of Oral GLP-1 Agonist
Figure 74. Channels of Distribution
Figure 75. Global Oral GLP-1 Agonist Sales Market Forecast by Region (2025-2030)
Figure 76. Global Oral GLP-1 Agonist Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Oral GLP-1 Agonist Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Oral GLP-1 Agonist Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Oral GLP-1 Agonist Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Oral GLP-1 Agonist Revenue Market Share Forecast by Application (2025-2030)